Recent Advances in Traditional Chinese Medicine for Kidney Disease

American Journal of Kidney Diseases

Volumn 66, Issue 3, 2015, Pages 513-522

  Zhong, Yifei ^a   Menon, Madhav C ^b   Deng, Yueyi ^a   Chen, Yiping ^a   He, John Cijiang ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

alternative medicine; animal models; anti fibrotic; anti inflammatory; anti oxidant; clinical trials; glomerular disease; herbal medicine; immunomodulation; Index Words Chronic kidney disease (CKD); inflammation; renal disease; review; traditional Chinese medicine (TCM)

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT;

ABELMOSCHUS; ABELMOSCHUS MANIHOT; ANTIFIBROTIC EFFFECT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTRAGALUS MEMBRANACEUS; CHINESE MEDICINE; DRUG EFFECT; HUMAN; IMMUNOMODULATION; KIDNEY DISEASE; META ANALYSIS (TOPIC); NONHUMAN; PAEONIA SUFFRUTICOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TRIPTERYGIUM WILFORDII; DRUG EFFECTS; FIBROSIS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; OXIDATIVE STRESS; PATHOLOGY; TREATMENT OUTCOME;

DRUGS, CHINESE HERBAL; FIBROSIS; HUMANS; IMMUNOMODULATION; INFLAMMATION; KIDNEY; KIDNEY DISEASES; MEDICINE, CHINESE TRADITIONAL; OXIDATIVE STRESS; TREATMENT OUTCOME;

EID: 84939571755     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.04.013     Document Type: Review

References (85)

1. D. de Zeeuw Unmet need in renal protection - do we need a more comprehensive approach? Contrib Nephrol 171 2011 157 160
2. Z. Xie, and A. Liang [New theoretical study on the biological origins of Chinese medicinal herbs] Zhongguo Zhong Yao Za Zhi 20 1995 259 261 318
3. L.D. Li, Y.Z. Jing, and Y.O. Li [Integrating traditional and Western medicine to research and develop Chinese new drugs] Zhongguo Zhong Xi Yi Jie He Za Zhi 16 1996 301 304
4. X. Li, and H. Wang Chinese herbal medicine in the treatment of chronic kidney disease Adv Chronic Kidney Dis 12 2005 276 281
5. Y. Zhong, Y. Deng, Y. Chen, P.Y. Chuang, and J. Cijiang He Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases Kidney Int 84 2013 1108 1118
6. K. Wojcikowski, D.W. Johnson, and G. Gobe Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies J Lab Clin Med 147 2006 160 166
7. Q. Qin, J. Niu, Z. Wang, W. Xu, Z. Qiao, and Y. Gu Astragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kappaB pathways in advanced glycation end product-stimulated macrophages Int J Mol Sci 13 2012 8379 8387
8. Y.Y. Qiu, J.X. Zhu, T. Bian, and et al. Protective effects of astragaloside IV against ovalbumin-induced lung inflammation are regulated/mediated by T-bet/GATA-3 Pharmacology 94 2014 51 59
9. J. Zhao, P. Yang, F. Li, and et al. Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis PLoS One 7 2012 e44938
10. X.P. Huang, Y.Y. Qiu, B. Wang, and et al. Effects of astragaloside IV combined with the active components of Panax notoginseng on oxidative stress injury and nuclear factor-erythroid 2-related factor 2/heme oxygenase-1 signaling pathway after cerebral ischemia-reperfusion in mice Pharmacogn Mag 10 2014 402 409
11. Y. Liu, F. Liu, Y. Yang, and et al. Astragalus polysaccharide ameliorates ionizing radiation-induced oxidative stress in mice Int J Biol Macromol 68 2014 209 214
12. Y. Cao, Y. Ruan, T. Shen, and et al. Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways Oxid Med Cell Longev 2014 2014 674219
13. W. Qi, J. Niu, Q. Qin, Z. Qiao, and Y. Gu Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells Cell Stress Chaperones 19 2014 105 114
14. Q. Wang, B. Xiao, S. Cui, and et al. Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD Dis Model Mech 7 2014 1385 1395
15. R. Han, M. Rostami-Yazdi, S. Gerdes, and U. Mrowietz Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases Br J Clin Pharmacol 74 2012 424 436
16. Q. Liang, J. Zhang, W. Tang, Q. Geng, X. Xu, and W. Jiang Triptolide attenuates acute small-for-size liver graft injury in rats by inhibition of Toll-like receptor 4 Transplant Proc 46 2014 3303 3308
17. M. Chen, Z. Lv, W. Zhang, and et al. Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-kappaB in a murine model of asthma Mol Immunol 64 2014 99 105
18. Y. Lu, Y. Zhang, L. Li, and et al. TAB1: a target of triptolide in macrophages Chem Biol 21 2014 246 256
19. B.Z. Zhang, X.T. Guo, J.W. Chen, and et al. Saikosaponin-d attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72 Am J Chin Med 42 2014 1261 1277
20. Y. Zhong, X. Zhang, X. Cai, K. Wang, Y. Chen, and Y. Deng Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats PLoS One 9 2014 e85690
21. Y. Tu, W. Sun, Y.G. Wan, and et al. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, ameliorates adriamycin-induced renal inflammation and glomerular injury via inhibiting p38MAPK signaling pathway activity in rats J Ethnopharmacol 147 2013 311 320
22. Y. Yamaguchi, S. Kagota, K. Nakamura, K. Shinozuka, and M. Kunitomo Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis Phytother Res 14 2000 647 649
23. M. Zhang, L. Feng, J. Gu, and et al. The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats Oxid Med Cell Longev 2014 2014 463815
24. M.H. Zhang, L. Feng, M.M. Zhu, J.F. Gu, C. Wu, and X.B. Jia Antioxidative and anti-inflammatory activities of paeoniflorin and oxypaeoniflora on AGEs-induced mesangial cell damage Planta Med 79 2013 1319 1323
25. W. Huang, L. Li, X. Tian, and et al. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factorbeta/Smad pathway in rats Mol Med Rep 11 2015 805 814
26. Z. Li, L. Zhang, W. He, C. Zhu, J. Yang, and M. Sheng Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-beta1 (TGF-beta1) pathway in rats submitted to peritoneal dialysis Int J Mol Sci 15 2014 12959 12971
27. J. Gu, K. Liu, H. Li, X. Wang, and K. Yang Astragalus saponin attenuates the expression of fibrosis-related molecules in irradiated cardiac fibroblasts Acta Biochim Biophys Sin (Shanghai) 46 2014 492 501
28. W. Rui, L. Xie, X. Liu, and et al. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription J Ethnopharmacol 151 2014 198 209
29. H. Wang, J. Li, L. Yu, Y. Zhao, and W. Ding Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis Life Sci 74 2004 1645 1658
30. L. Meng, L. Qu, J. Tang, S.Q. Cai, H. Wang, and X. Li A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, enhanced nitric oxide production in obstructed rat kidney Vascul Pharmacol 47 2007 174 183
31. J. Song, L. Meng, S. Li, L. Qu, and X. Li A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats Vascul Pharmacol 50 2009 185 193
32. L. Meng, V. Van Putten, L. Qu, and et al. Altered expression of genes profiles modulated by a combination of Astragali radix and Angelicae sinensis radix in obstructed rat kidney Planta Med 76 2010 1431 1438
33. Q. Wang, X. Shao, W. Xu, and et al. Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells Ren Fail 36 2014 400 406
34. Y.G. Wan, X.Y. Che, W. Sun, and et al. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. F., a natural regulator of TGF-beta1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo J Ethnopharmacol 151 2014 1079 1089
35. X.P. Yuan, X.S. He, C.X. Wang, L.S. Li, and Q. Fu Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction Nephrology (Carlton) 16 2011 200 210
36. S.J. Wu, K.W. Tam, Y.H. Tsai, C.C. Chang, and J.C. Chao Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats Am J Chin Med 38 2010 99 111
37. X. Wang, Q. Wang, F.J. Burczynski, W. Kong, and Y. Gong Saikosaponin a of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation Phytomedicine 20 2013 1330 1335
38. N. Zu, P. Li, N. Li, P. Choy, and Y. Gong Mechanism of saikosaponin-d in the regulation of rat mesangial cell proliferation and synthesis of extracellular matrix proteins Biochem Cell Biol 85 2007 169 174
39. Q. Gao, W.S. Qin, Z.H. Jia, and et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy Planta Med 76 2010 27 33
40. V. Vetvicka, and J. Vetvickova Natural immunomodulators and their stimulation of immune reaction: true or false? Anticancer Res 34 2014 2275 2282
41. A.S. Abuelsaad Supplementation with Astragalus polysaccharides alters Aeromonas-induced tissue-specific cellular immune response Microb Pathog 66 2014 48 56
42. L.F. Huang, Y.M. Yao, J.F. Li, and et al. The effect of astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro Fitoterapia 83 2012 1514 1522
43. A. Nalbantsoy, T. Nesil, O. Yilmaz-Dilsiz, G. Aksu, S. Khan, and E. Bedir Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species J Ethnopharmacol 139 2012 574 581
44. R. Zheng, Y. Deng, Y. Chen, and et al. Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway Phytother Res 26 2012 892 898
45. L. Ji, X. Chen, X. Zhong, and et al. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy BMC Complement Altern Med 14 2014 195
46. Q. Liu Triptolide and its expanding multiple pharmacological functions Int Immunopharmacol 11 2011 377 383
47. D. Qiu, and P.N. Kao Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. F Drugs R D 4 2003 1 18
48. C. Liu, Y. Zhang, X. Kong, and et al. Triptolide prevents bone destruction in the collagen-induced arthritis model of rheumatoid arthritis by targeting RANKL/RANK/OPG signal pathway Evid Based Complement Alternat Med 2013 2013 626038
49. S.H. Huang, G.J. Lin, C.H. Chu, and et al. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice Pancreas 42 2013 442 451
50. G. Zhang, J. Chen, Y. Liu, R. Yang, H. Guo, and Z. Sun Triptolide-conditioned dendritic cells induce allospecific T-cell regulation and prolong renal graft survival J Invest Surg 26 2013 191 199
51. L.J. Ho, W.L. Chang, A. Chen, P. Chao, and J.H. Lai Differential immunomodulatory effects by Tripterygium wilfordii Hook F-derived refined extract PG27 and its purified component PG490 (triptolide) in human peripheral blood T cells: potential therapeutics for arthritis and possible mechanisms explaining in part Chinese herbal theory "Junn-Chenn-Zuou-SS." J Transl Med 11 2013 294
52. Z.H. Chen, W.S. Qin, C.H. Zeng, and et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro Kidney Int 77 2010 974 988
53. X. Tao, W.S. Qin, C.H. Zeng, and et al. Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F Arthritis Rheum 58 2008 1774 1783
54. V.K. Wong, H. Zhou, S.S. Cheung, T. Li, and L. Liu Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation J Cell Biochem 107 2009 303 315
55. M.L. Ashour, and M. Wink Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action J Pharm Pharmacol 63 2011 305 321
56. W. Zhang, H. Li, H. Bu, and et al. Emodin inhibits the differentiation and maturation of dendritic cells and increases the production of regulatory T cells Int J Mol Med 29 2012 159 164
57. Y. Chen, Y. Deng, Z. Ni, and et al. Efficacy and safety of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial Am J Kidney Dis 62 2013 1068 1076
58. M.C. Menon, P.Y. Chuang, and J.C. He Shenqi particle: a novel therapy for idiopathic membranous nephropathy Am J Kidney Dis 62 2013 1027 1029
59. L. Zhang, P. Li, C.Y. Xing, and et al. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial Am J Kidney Dis 64 2014 57 65
60. Y.J. Wang, L.Q. He, W. Sun, and et al. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial J Ethnopharmacol 139 2012 757 764
61. D. Chen, Y. Ma, X. Wang, and et al. Triptolide-containing formulation in patients with autosomal dominant polycystic kidney disease and proteinuria: an uncontrolled trial Am J Kidney Dis 63 2014 1070 1072
62. L. Wu, J. Mao, X. Jin, and et al. Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China Biomed Res Int 2013 2013 292865
63. B. Zhu, Y. Wang, M. Jardine, and et al. Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis Am J Kidney Dis 62 2013 515 530
64. Y. Chen, Z. Gong, X. Chen, and et al. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome Cochrane Database Syst Rev 8 2013 CD008568
65. H.W. Zhang, Z.X. Lin, C. Xu, C. Leung, and L.S. Chan Astragalus (a traditional Chinese medicine) for treating chronic kidney disease Cochrane Database Syst Rev 10 2014 CD008369
66. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy J Ethnopharmacol 133 2011 412 419
67. H.W. Zhang, Z.X. Lin, Y.S. Tung, and et al. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease Cochrane Database Syst Rev 12 2014 CD008353
68. H. Wang, H. Song, J. Yue, J. Li, Y.B. Hou, and J.L. Deng Rheum officinale (a traditional Chinese medicine) for chronic kidney disease Cochrane Database Syst Rev 7 2012 CD008000
69. F.D. Debelle, J.L. Nortier, E.G. De Prez, and et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats J Am Soc Nephrol 13 2002 431 436
70. M.S. Ahmed, S.H. Hou, M.C. Battaglia, M.M. Picken, and D.J. Leehey Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus Am J Kidney Dis 50 2007 1028 1032
71. Z.L. Zhou, Y.X. Yang, J. Ding, Y.C. Li, and Z.H. Miao Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms Nat Prod Rep 29 2012 457 475
72. J. Liu, Z. Jiang, L. Liu, and et al. Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats Drug Chem Toxicol 34 2011 1 7
73. Y. Yang, Z. Liu, E. Tolosa, J. Yang, and L. Li Triptolide induces apoptotic death of T lymphocyte Immunopharmacology 40 1998 139 149
74. N. Yoshikawa, H. Ito, T. Sakai, and et al. [A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group] Nihon Jinzo Gakkai Shi 39 1997 503 506
75. PaW. Lu, and H. Chiu Discussion on Xiao Chai Hu Tang clinical application and its side effects Chinese Primary Health Care 22 2008 80 82
76. T. Asano, Y. Fujii, N. Numao, Y. Kageyama, and K. Kihara The efficiency of Sairei-to for retroperitoneal fibrosis: two case reports Hinyokika Kiyo 52 2006 543 547
77. X.Y. Lai, Y.Y. Zhao, and H. Liang [Studies on chemical constituents in flower of Abelmoschus manihot] Zhongguo Zhong Yao Za Zhi 31 2006 1597 1600
78. Chen YZ, Gong ZX, Cai GY, et al. Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: a systematic review [published online ahead of print December 9, 2014]. Chin J Integr Med. http://dx.doi.org/10.1007/s11655-014-1891-6.
79. R.R. Paterson Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69 2008 1469 1495
80. Y. Li, W.J. Xue, P.X. Tian, and et al. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation Transplant Proc 41 2009 1565 1569
81. G. Shao [Treatment of hyperlipidemia with cultivated Cordyceps - a double-blind, randomized placebo control trial] Zhong Xi Yi Jie He Za Zhi 5 1985 652 654 642
82. R.H. Xu, X.E. Peng, G.Z. Chen, and G.L. Chen Effects of Cordyceps sinensis on natural killer activity and colony formation of B16 melanoma Chin Med J (Engl) 105 1992 97 101
83. J. Yang Clinical use and side effects of Rheum palmatum L China Pract Med 7 2012 230-131
84. X. Wu, H. Chen, X. Chen, and Z. Hu Determination of paeonol in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies following oral administration of Moutan cortex decoction Biomed Chromatogr 17 2003 504 508
85. Y.K. Koo, J.M. Kim, J.Y. Koo, and et al. Platelet anti-aggregatory and blood anti-coagulant effects of compounds isolated from Paeonia lactiflora and Paeonia suffruticosa Pharmazie 65 2010 624 628